FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 108-46-3, stock 544.3g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 25392-41-0, stock 690g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 3886-69-9, stock 887.4g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1394138-45-4, stock 918.4g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1394138-46-5, stock 118.1g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1000414-38-9, stock 303.4g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1258399-02-8, stock 427.7g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1394138-49-8, stock 407.5g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 505-10-2, stock 699.6g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 187722-18-5, stock 809.4g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 263400-88-0, stock 373.1g, white powder, assay by HPLC 100%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 7463-51-6, stock 465.6g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1372195-69-1, stock 943.2g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 87199-16-4, stock 134.6g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1000413-84-2, stock 859.7g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1000413-85-3, stock 898.5g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1394138-49-8, stock 874.6g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 108-46-3, stock 921.5g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 726174-52-3, stock 202.6g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 805250-17-3, stock 449.7g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| Fasiglifam, 1000413-72-8, Fasiglifam Intermediate 1000413-85-3, stock 872g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
